Gene · 5733
Papers2,527
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,527
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lipids as Targets for Renal Cell Carcinoma Therapy. | Int J Mol Sci | 2023 | 36834678 | PubTator, text mining | PubMed |
| Mechanisms of Transmission and Processing of Pain: A Narrative Review. | Int J Environ Res Public Health | 2023 | 36833753 | PubTator, text mining | PubMed |
| Homozygous Missense Variant in the Solute Carrier Organic Anion Transporter 2A1 (SLCO2A1) Gene Underlies Isolated Nail Clubbing. | Genes (Basel) | 2023 | 36833358 | PubTator, text mining | PubMed |
| Synergies of Radiomics and Transcriptomics in Lung Cancer Diagnosis: A Pilot Study. | Diagnostics (Basel) | 2023 | 36832225 | PubTator, text mining | PubMed |
| The Role of COX-2 and PGE2 in the Regulation of Immunomodulation and Other Functions of Mesenchymal Stromal Cells. | Biomedicines | 2023 | 36830980 | PubTator, text mining | PubMed |
| Inflammatory response: The target for treating hyperpigmentation during the repair of a burn wound. | Front Immunol | 2023 | 36817442 | PubTator, text mining | PubMed |
| The 5-lipoxygenase/cyclooxygenase-2 cross-over metabolite, hemiketal E2, enhances VEGFR2 activation and promotes angiogenesis. | J Biol Chem | 2023 | 36813233 | PubTator, text mining | PubMed |
| An immune-related prognostic signature associated with immune landscape and therapeutic responses in gastric cancer. | Aging (Albany NY) | 2023 | 36812479 | PubTator, text mining | PubMed |
| Hydroxylation markedly alters how the polychlorinated biphenyl (PCB) congener, PCB52, affects gene expression in human preadipocytes. | Toxicol In Vitro | 2023 | 36804509 | PubTator, text mining | PubMed |
| Spatial Transcriptomics Depict Ligand-Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors. | Cancer Res | 2023 | 36787106 | PubTator, text mining | PubMed |
| Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells. | Front Oncol | 2023 | 36776289 | PubTator, text mining | PubMed |
| Additively-Manufactured High-Concentration Nanocellulose Composites: Structure and Mechanical Properties. | Polymers (Basel) | 2023 | 36771967 | PubTator, text mining | PubMed |
| Expression of Progesterone Receptor A as an Independent Negative Prognosticator for Cervical Cancer. | Int J Mol Sci | 2023 | 36769131 | PubTator, text mining | PubMed |
| A Phytoprostane from Gracilaria longissima Increases Platelet Activation, Platelet Adhesion to Leukocytes and Endothelial Cell Migration by Potential Binding to EP3 Prostaglandin Receptor. | Int J Mol Sci | 2023 | 36769052 | PubTator, text mining | PubMed |
| Non-Coding RNAs in Pulmonary Diseases: Comparison of Different Airway-Derived Biosamples. | Int J Mol Sci | 2023 | 36768329 | PubTator, text mining | PubMed |
| Profiling of G-Protein Coupled Receptors in Adipose Tissue and Differentiating Adipocytes Offers a Translational Resource for Obesity/Metabolic Research. | Cells | 2023 | 36766718 | PubTator, text mining | PubMed |
Synthesis and Significance of Arachidonic Acid, a Substrate for Cyclooxygenases, Lipoxygenases, and Cytochrome P450 Pathways in the Tumorigenesis of Glioblastoma Multiforme, Including a Pan-Cancer Comparative Analysis. | Cancers (Basel) | 2023 | 36765904 | PubTator, text mining | PubMed |
| How to train a self-driving vehicle: On the added value (or lack thereof) of curriculum learning and replay buffers. | Front Artif Intell | 2023 | 36762255 | PubTator, text mining | PubMed |
| Molecular Targets of Shenqi Dihuang, A Traditional Chinese Herbal Medicine, and Its Potential Role in Renal Cell Carcinoma Therapy. | Genet Res (Camb) | 2023 | 36741922 | PubTator, text mining | PubMed |
| Lipid-induced transcriptomic changes in blood link to lipid metabolism and allergic response. | Nat Commun | 2023 | 36725846 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5733/papers?page=12